AU6223098A - Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies - Google Patents

Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies

Info

Publication number
AU6223098A
AU6223098A AU62230/98A AU6223098A AU6223098A AU 6223098 A AU6223098 A AU 6223098A AU 62230/98 A AU62230/98 A AU 62230/98A AU 6223098 A AU6223098 A AU 6223098A AU 6223098 A AU6223098 A AU 6223098A
Authority
AU
Australia
Prior art keywords
dementia
late
disease
lewy bodies
onset alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62230/98A
Inventor
Christopher Miles Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9703139.7A external-priority patent/GB9703139D0/en
Priority claimed from GBGB9703939.0A external-priority patent/GB9703939D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU6223098A publication Critical patent/AU6223098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU62230/98A 1997-02-14 1998-02-13 Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies Abandoned AU6223098A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9703139 1997-02-14
GBGB9703139.7A GB9703139D0 (en) 1997-02-14 1997-02-14 Method of determining susceptibility to late-onset alzheimer's disease
GBGB9703939.0A GB9703939D0 (en) 1997-02-26 1997-02-26 Method of determining susceptibilty to late-onset alzheimer's disease and dementia with lewy bodies
GB9703939 1997-02-26
PCT/GB1998/000467 WO1998036091A1 (en) 1997-02-14 1998-02-13 Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies

Publications (1)

Publication Number Publication Date
AU6223098A true AU6223098A (en) 1998-09-08

Family

ID=26311003

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62230/98A Abandoned AU6223098A (en) 1997-02-14 1998-02-13 Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies

Country Status (2)

Country Link
AU (1) AU6223098A (en)
WO (1) WO1998036091A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382137D1 (en) * 1982-07-30 1991-02-28 Bernard Francois Mach DNA SEQUENCE ENCODING FOR THE DR BETA CHAIN LOCUS OF THE HUMAN LYMPHOCYTANTIGEN COMPLEX AND POLYPEPTIDES, DIAGNOSTIC TYPING METHODS AND PRODUCTS RELATING TO THIS.
GB9002625D0 (en) * 1990-02-06 1990-04-04 Univ Singapore Human leukocyte antigen typing
US5468611A (en) * 1990-06-27 1995-11-21 The Blood Center Research Foundation, Inc. Method for HLA typing
CA2049449C (en) * 1990-08-20 1999-08-10 Fumiya Obata Hla-dr antigen gene and its nucleotide sequence and its use
FR2679252B1 (en) * 1991-07-17 1993-12-10 Bio Merieux PROBE SYSTEM FOR HLA DR TYPING, AND TYPING METHOD USING THE SAME.

Also Published As

Publication number Publication date
WO1998036091A1 (en) 1998-08-20

Similar Documents

Publication Publication Date Title
IL112050A0 (en) Methods of inhibiting alzheimer's disease
GB9524319D0 (en) Improvements in or relating to the recording of images
IL105216A0 (en) Method and kit for the diagnosis of alzheimer's disease
AU8897298A (en) System and method of noninvasevely determining a patient's susceptibility to arrhythmia
GB9316727D0 (en) Models of alzheimers's disease
AU7397094A (en) Prevention and treatment of alzheimer's disease
HU9403657D0 (en) Methods of inhibiting pulmonary hypertenzive diseases
AU1189395A (en) Apolipoprotein e polymorphism and alzheimer's disease
EP0748376A4 (en) Rna editing enzyme and methods of use thereof
EP0842189A4 (en) Early onset alzheimer's disease gene and gene products
AU6223098A (en) Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies
GB9615682D0 (en) The process of asphalt purification and the composition of modified asphalt
EP0728216A4 (en) Detection of alzheimer's disease and other diseases using an improved photoaffinity labeling method
EP0866799A4 (en) Apolipoprotein e2 and treatment of alzheimer's disease
GB9703939D0 (en) Method of determining susceptibilty to late-onset alzheimer's disease and dementia with lewy bodies
AU7622798A (en) Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
IL117917A0 (en) H influenzae HxuB and HxuC genes proteins and methods of use
GB9703139D0 (en) Method of determining susceptibility to late-onset alzheimer's disease
GB2289973B (en) Improvements in and relating to the display of information
GB9323826D0 (en) Diagnosis of alzheimer's disease
GB2295395B (en) Models of Alzheimer's disease
ZA937536B (en) Methods of detecting Alzheimer's Disease
AU7467094A (en) Method of diagnosing alzheimer's disease
GB9507219D0 (en) Improvements in or relating to the recording of images
HU9401502D0 (en) Intermediates useful in the preparation of pyranyl-cyanoguanidine derivatives and methods of preparing same